Home / Central Data Catalog / NGA_2017_HRBFIE-EL_V01_M
central

State Health Investment Project: Impact Evaluation Endline Survey, 2017

Nigeria, 2017
Get Microdata
Reference ID
NGA_2017_HRBFIE-EL_v01_M
Producer(s)
Eeshani Kandpal (World Bank)
Metadata
DDI/XML JSON
Study website
Created on
Dec 05, 2022
Last modified
Aug 28, 2024
Page views
102357
Downloads
316

Data file: staff_roster_noid.dta

This file contains data from the Healthcare Provider Interviews (HF7) Questionnaire on the following topics/sections:
- Healthcare provider satisfaction
- Staff training
- Hours and duties
- Salary
- Other compensation
- Internal and external supervision
- Supplemental income
- Whole well-being index
- Healthcare provider satisfaction
- Personal drive
- Innovation
- Staff knowledge
- Protocol-based vignettes
- PBF knowledge
- Partograph

Cases: 3222
Variables: 633

Variables

HF7_Q1104_oth
Other;specify
HF7_Q1105__1
11.05: Imagine a situation where there are not enough HEALTH CARE PROVIDERs in t
HF7_Q1105__2
11.05: Imagine a situation where there are not enough HEALTH CARE PROVIDERs in t
HF7_Q1105__3
11.05: Imagine a situation where there are not enough HEALTH CARE PROVIDERs in t
HF7_Q1105__4
11.05: Imagine a situation where there are not enough HEALTH CARE PROVIDERs in t
HF7_Q1105__5
11.05: Imagine a situation where there are not enough HEALTH CARE PROVIDERs in t
HF7_Q1105__6
11.05: Imagine a situation where there are not enough HEALTH CARE PROVIDERs in t
HF7_Q1105__7
11.05: Imagine a situation where there are not enough HEALTH CARE PROVIDERs in t
HF7_Q1105__8
11.05: Imagine a situation where there are not enough HEALTH CARE PROVIDERs in t
HF7_Q1105_oth
Other;specify
HF7_Q1201
Q12.01: IS THE STAFF A SERVICE PROVIDER (ANY CLINICAL SERVICE)?
HF7_Q1202A1
Q12.02a_1: BCG in weeks
HF7_Q1202A2
Q12.02a: Is %HF7_Q1202A1% in weeks or months?
HF7_Q1202B1
Q12.02b_1: Pentavalent1 in weeks
HF7_Q1202B2
Q12.02b: Is %HF7_Q1202B1% in weeks or months?
HF7_Q1202C1
Q12.02c: At what age should a child receive Pentavalent 2 vaccines?
HF7_Q1202C2
Q12.02c: Is %HF7_Q1202C1% in weeks or months?
HF7_Q1202D1
Q12.02d: At what age should a child receive DPT2 vaccines?
HF7_Q1202D2
Q12.02d: Is %HF7_Q1202D1% in weeks or months?
HF7_Q1202E1
Q12.02e: At what age should a child receive Yellow Fever vaccines?
HF7_Q1202E2
Q12.02e: Is %HF7_Q1202E1% in weeks or months?
HF7_Q1202F1
Q12.02f: At what age should a child receive Measles vaccines?
HF7_Q1202F2
Q12.02f: Is %HF7_Q1202F1% in weeks or months?
HF7_Q1203__1
Q12.03: What are the danger signs of tuberculosis?:LOSS OF WEIGHT
HF7_Q1203__2
Q12.03: What are the danger signs of tuberculosis?:LOSS OF APPETITE
HF7_Q1203__3
Q12.03: What are the danger signs of tuberculosis?:FEVER
HF7_Q1203__4
Q12.03: What are the danger signs of tuberculosis?:COUGH FOR MORE THAN 15 DAYS
HF7_Q1203__5
Q12.03: What are the danger signs of tuberculosis?:NIGHT SWEATING
HF7_Q1204
Q12.04: Imagine a mother brings in her 9 month old child for routine immunizatio
HF7_Q1205
Q12.05: Do you feel comfortable providing Sexual and Reproductive Health Service
HF7_Q1206
Q12.06: Do unmarried adolescents need permission from a family member to use ASR
HF7_Q1207__1
Q12.07: If a 13 year old female came to you for contraceptives what would you do
HF7_Q1207__2
Q12.07: If a 13 year old female came to you for contraceptives what would you do
HF7_Q1207__3
Q12.07: If a 13 year old female came to you for contraceptives what would you do
HF7_Q1207__4
Q12.07: If a 13 year old female came to you for contraceptives what would you do
HF7_Q1207__5
Q12.07: If a 13 year old female came to you for contraceptives what would you do
HF7_Q1207__6
Q12.07: If a 13 year old female came to you for contraceptives what would you do
HF7_Q1208__1
Q12.08: Do you know the policies related to Sexual and Reproductive Health servi
HF7_Q1208__2
Q12.08: Do you know the policies related to Sexual and Reproductive Health servi
HF7_Q1208__3
Q12.08: Do you know the policies related to Sexual and Reproductive Health servi
HF7_Q1209__1
Q12.09: CASE SCENARIO 1:GIVE SP (E.G. FANSIDAR, AMALAR, MALOXINE, MALDOX) AS DI
HF7_Q1209__2
Q12.09: CASE SCENARIO 1:COUNSEL HER TO SLEEP UNDER LONG LASTING INSECTICIDE TRE
HF7_Q1209__3
Q12.09: CASE SCENARIO 1:COUNSEL HER TO COME FOR SECOND DOSE OF SP
HF7_Q1209__4
Q12.09: CASE SCENARIO 1:ADVICE ON ADEQUATE NUTRITION
HF7_Q1209__5
Q12.09: CASE SCENARIO 1:EDUCATE HER TO SCREEN WINDOWS AND DOORS WITH NET
HF7_Q1209__6
Q12.09: CASE SCENARIO 1:PROVIDE ADVICE ON ENVIRONMENTAL SANITATION AND HYGIENE
HF7_Q1209__7
Q12.09: CASE SCENARIO 1:ENCOURAGE ON THE USE OF INSECTICIDE
HF7_Q1210__1
Q12.10: CASE SCENARIO 2:TREAT FOR MALARIA WITH ARTEMISININ-BASED COMBINATION THE
HF7_Q1210__8
Q12.10: CASE SCENARIO 2:TREAT MALARIA WITH ARTESUNATE (AS)/QUININE/ARTEMETHER TH
HF7_Q1210__2
Q12.10: CASE SCENARIO 2:COUNSEL/HEALTH EDUCATE ON HOW TO COMPLETE TREATMENT AND
HF7_Q1210__3
Q12.10: CASE SCENARIO 2:REFER TO THE NEAREST HOSPITAL
HF7_Q1210__4
Q12.10: CASE SCENARIO 2:ENCOURAGE FLUID INTAKE
HF7_Q1210__5
Q12.10: CASE SCENARIO 2:TEPID SPONGE AND TEMPERATURE, PULSE, RESPIRATION (TPR)
HF7_Q1210__6
Q12.10: CASE SCENARIO 2:ADVISE PATIENT TO RETURN TO PHC AFTER TWO DAYS IF THERE
HF7_Q1210__7
Q12.10: CASE SCENARIO 2:ADVISE PATIENT TO RETURN TO PHC IMMEDIATELY IF THE CONDI
HF7_Q1211__1
Q12.11: CASE SCENARIO 3:GIVE RECTAL DIAZEPAM OR SLOW IV DIAZEPAM OR PARAALDEHYDE
HF7_Q1211__2
Q12.11: CASE SCENARIO 3:CIRCULATION, COMA, CONVULSION AND DEHYDRATION
HF7_Q1211__3
Q12.11: CASE SCENARIO 3:CARRY OUT A THOROUGH EXAMINATION OF THE PATIENT COVERING
HF7_Q1211__4
Q12.11: CASE SCENARIO 3:CARRY OUT BEDSIDE TEST FOR BLOOD SUGAR AND TREAT HYPOGLA
HF7_Q1211__5
Q12.11: CASE SCENARIO 3:DO MALARIA RDT AND/OR MICROSCOPY TO IDENTIFY PARASITE TY
HF7_Q1211__6
Q12.11: CASE SCENARIO 3:ESTIMATE HB CONCENTRATION AND HCT. TRANSFUSE BLOOD/PCV I
HF7_Q1211__7
Q12.11: CASE SCENARIO 3:DO FULL BLOOD COUNT
HF7_Q1211__8
Q12.11: CASE SCENARIO 3:DO UREA OR CRAETININE AND PLASMA ELECTROLYTES
HF7_Q1211__9
Q12.11: CASE SCENARIO 3:DO LUMBER PUNCTURE IF INDICATED
HF7_Q1211__10
Q12.11: CASE SCENARIO 3:DO CHEST X RAY
HF7_Q1211__11
Q12.11: CASE SCENARIO 3:GIVE OXYGEN IF THERE ARE SIGNS OF METABOLIC ACIDOSIS
HF7_Q1211__12
Q12.11: CASE SCENARIO 3:ESTABLISH IV LINE AND RESTORE CIRCULATING VOLUME WITH SA
HF7_Q1211__13
Q12.11: CASE SCENARIO 3:INSERT NG TUBE TO MINIMIZE RISK OF ASPIRATION PNEUMONIA
HF7_Q1211__14
Q12.11: CASE SCENARIO 3:INSERT URINARY CATHETER IF RENAL FAILURE IS SUSPECTED OR
HF7_Q1211__15
Q12.11: CASE SCENARIO 3:GIVE BROAD SPECTRUM ANTIBIOTIC
HF7_Q1211__16
Q12.11: CASE SCENARIO 3:TREAT MALARIA WITH ARTESUNATE/QUININE/ARTEMETHER THROUGH
HF7_Q1212__1
Q12.12 CASE SCENARIO 4:RECOMMENDS URGENT REFERRAL TO A HOSPITAL
HF7_Q1212__2
Q12.12 CASE SCENARIO 4:ADMINISTER RINGER LACTATE OR NORMAL SALINE IV SOLUTION
HF7_Q1212__3
Q12.12 CASE SCENARIO 4:ADMINISTER LIQUID BY NASO-GASTRIC TUBE
HF7_Q1212__4
Q12.12 CASE SCENARIO 4:INJECT ONE DOSE OF AN INJECTABLE ANTIBIOTIC
HF7_Q1212__5
Q12.12 CASE SCENARIO 4:INJECT ONE DOSE OF A SECOND ANTIBIOTIC (IF REFERRAL IS DI
HF7_Q1212__6
Q12.12 CASE SCENARIO 4:PRESCRIBE INJECTABLE ANTIBIOTIC FOR FIVE DAYS
HF7_Q1212__7
Q12.12 CASE SCENARIO 4:GIVE ONE DOSE OF AN ORAL ANTIBIOTIC
HF7_Q1212__8
Q12.12 CASE SCENARIO 4:PRESCRIBE ORAL ANTIBIOTICS FOR FIVE DAYS
HF7_Q1212__9
Q12.12 CASE SCENARIO 4:GIVE ONE DOSE OF ORAL ANTIMALARIAL
HF7_Q1212__10
Q12.12 CASE SCENARIO 4:PRESCRIBE QUININE FOR FIVE DAYS
HF7_Q1212__11
Q12.12 CASE SCENARIO 4:PRESCRIBE ORAL ANTIMALARIALS FOR 3 DAYS
HF7_Q1212__12
Q12.12 CASE SCENARIO 4:ADMINISTER ORS AT THE FACILITY
HF7_Q1212__13
Q12.12 CASE SCENARIO 4:ADVISE ON GIVING ORS ON THE WAY TO HOSPITAL
HF7_Q1212__14
Q12.12 CASE SCENARIO 4:PRESCRIBE ORS FOR HOME TREATMENT
HF7_Q1212__15
Q12.12 CASE SCENARIO 4:GIVE ONE DOSE OF PARACETAMOL
HF7_Q1212__16
Q12.12 CASE SCENARIO 4:PRESCRIBE PARACETAMOL FOR HOME TREATMENT
HF7_Q1212__17
Q12.12 CASE SCENARIO 4:GIVE ONE DOSE OF VITAMIN A
HF7_Q1212__18
Q12.12 CASE SCENARIO 4:TREAT TO PREVENT LOW BLOOD SUGAR
HF7_Q1212__19
Q12.12 CASE SCENARIO 4:RECOMMENDS TO CONTINUE BREASTFEEDING
HF7_Q1212__20
Q12.12 CASE SCENARIO 4:RECOMMENDS TO GIVE FOOD AND FLUIDS OTHER THAN BREASTMILK
HF7_Q1213__1
Q12.13: CASE SCENARIO 5:REFER URGENTLY TO A HOSPITAL
HF7_Q1213__2
Q12.13: CASE SCENARIO 5:ADMINISTER RINGER LACTATE OR NORMAL SALINE IV SOLUTION
HF7_Q1213__3
Q12.13: CASE SCENARIO 5:ADMINISTER LIQUID BY NASO-GASTRIC TUBE
HF7_Q1213__4
Q12.13: CASE SCENARIO 5:INJECT ONE DOSE OF AN INJECTABLE ANTIBIOTIC
HF7_Q1213__5
Q12.13: CASE SCENARIO 5:INJECT ONE DOSE OF A SECOND ANTIBIOTIC
HF7_Q1213__6
Q12.13: CASE SCENARIO 5:PRESCRIBE INJECTABLE ANTIBIOTIC FOR FIVE DAYS
HF7_Q1213__7
Q12.13: CASE SCENARIO 5:GIVE ONE DOSE OF AN ORAL ANTIBIOTIC
HF7_Q1213__8
Q12.13: CASE SCENARIO 5:PRESCRIBE ORAL ANTIBIOTICS FOR FIVE DAYS
HF7_Q1213__9
Q12.13: CASE SCENARIO 5:GIVE ONE DOSE OF ORAL ANTIMALARIAL
HF7_Q1213__10
Q12.13: CASE SCENARIO 5:PRESCRIBE QUININE FOR FIVE DAYS
HF7_Q1213__11
Q12.13: CASE SCENARIO 5:PRESCRIBE ORAL ANTIMALARIALS FOR 3 DAYS
HF7_Q1213__12
Q12.13: CASE SCENARIO 5:ADMINISTER ORS AT THE FACILITY
HF7_Q1213__13
Q12.13: CASE SCENARIO 5:ADVISE ON GIVING ORS ON THE WAY TO HOSPITAL
HF7_Q1213__14
Q12.13: CASE SCENARIO 5:PRESCRIBE ORS FOR HOME TREATMENT
HF7_Q1213__15
Q12.13: CASE SCENARIO 5:GIVE ONE DOSE OF PARACETAMOL
HF7_Q1213__16
Q12.13: CASE SCENARIO 5:PRESCRIBE PARACETAMOL FOR HOME TREATMENT
HF7_Q1213__17
Q12.13: CASE SCENARIO 5:GIVE ONE DOSE OF VITAMIN A
HF7_Q1213__18
Q12.13: CASE SCENARIO 5:TREAT TO PREVENT LOW BLOOD SUGAR
HF7_Q1213__19
Q12.13: CASE SCENARIO 5:RECOMMEND TO CONTINUE BREASTFEEDING
HF7_Q1213__20
Q12.13: CASE SCENARIO 5:RECOMMEND TO GIVE FOOD AND FLUIDS OTHER THAN BREASTMILK
HF7_Q1213__21
Q12.13: CASE SCENARIO 5:RECOMMEND TO KEEP CHILD WARM
HF7_Q1214__1
Q12.14: CASE SCENARIO 6:VAGINAL BLEEDING
HF7_Q1214__2
Q12.14: CASE SCENARIO 6:CONVULSIONS
HF7_Q1214__3
Q12.14: CASE SCENARIO 6:SEVERE HEADACHE OR BLURRED VISION
HF7_Q1214__4
Q12.14: CASE SCENARIO 6:FEVER AND TOO WEAK TO GET OUT OF BED
HF7_Q1214__5
Q12.14: CASE SCENARIO 6:SEVERE ABDOMINAL PAIN
HF7_Q1214__6
Q12.14: CASE SCENARIO 6:BABY PRESENT WITH BUTTOCKS, HANDS AND CORD
HF7_Q1214__7
Q12.14: CASE SCENARIO 6:LABOUR PROLONG MORE THAN 12 HOURS
HF7_Q1214__8
Q12.14: CASE SCENARIO 6:PREMATURE RUPTURE OF MEMBRANE
HF7_Q1214__9
Q12.14: CASE SCENARIO 6:PLACENTA DELAY MORE THAN 30 MINUTES
HF7_Q1214__10
Q12.14: CASE SCENARIO 6:SWELLING OF FACE, FINGERS, LEGS
HF7_Q1301__1
13.01A.NUMBER OF PRIOR PREGNANCIES:NUMBER OF PRIOR PREGNANCIES
HF7_Q1301__2
13.01A.NUMBER OF PRIOR PREGNANCIES:NUMBER OF LIVE BIRTHS
HF7_Q1301__3
13.01A.NUMBER OF PRIOR PREGNANCIES:NUMBER OF MISCARRIAGES/STILLBIRTHS/ABORTIONS
HF7_Q1301__4
13.01A.NUMBER OF PRIOR PREGNANCIES:ANY BLEEDING DURING PREVIOUS LABOR
HF7_Q1301__5
13.01A.NUMBER OF PRIOR PREGNANCIES:HOW WAS THE LAST CHILD DELIVERED? (NATURAL? C
HF7_Q1301__6
13.01A.NUMBER OF PRIOR PREGNANCIES:BIRTH WEIGHT OF PREVIOUS CHILD
HF7_Q1301__7
13.01A.NUMBER OF PRIOR PREGNANCIES:HISTORY OF GENETIC ANOMALIES
HF7_Q1301__8
13.01A.NUMBER OF PRIOR PREGNANCIES:TETANUS IMMUNIZATIONS?
HF7_Q1301__9
13.01A.NUMBER OF PRIOR PREGNANCIES:BIRTH INTERVAL
HF7_Q1301__10
13.01A.NUMBER OF PRIOR PREGNANCIES:CONVULSIONS
HF7_Q1302__1
LAST MENSTRUAL PERIOD (LMP):LAST MENSTRUAL PERIOD (LMP)
HF7_Q1302__2
LAST MENSTRUAL PERIOD (LMP):ANY HEALTH PROBLEMS NOW?
HF7_Q1302__3
LAST MENSTRUAL PERIOD (LMP):ANY CONTRACTIONS?
HF7_Q1302__4
LAST MENSTRUAL PERIOD (LMP):ANY VAGINAL BLEEDING?
HF7_Q1302__5
LAST MENSTRUAL PERIOD (LMP):ANY WEIGHT LOSS/GAIN?
HF7_Q1302__6
LAST MENSTRUAL PERIOD (LMP):ANY NAUSEA OR VOMITING?
HF7_Q1302__7
LAST MENSTRUAL PERIOD (LMP):TAKING MEDICATIONS NOW?
HF7_Q1302__8
LAST MENSTRUAL PERIOD (LMP):TETANUS IMMUNIZATIONS?
HF7_Q1303__1
ANY HISTORY OF HIGH BLOOD PRESSURE?:ANY HISTORY OF HIGH BLOOD PRESSURE?
HF7_Q1303__2
ANY HISTORY OF HIGH BLOOD PRESSURE?:ANY HISTORY OF DIABETES?
HF7_Q1303__3
ANY HISTORY OF HIGH BLOOD PRESSURE?:ANY PREVIOUS STI, INCLUDING HIV?
HF7_Q1303__4
ANY HISTORY OF HIGH BLOOD PRESSURE?:ANY PREVIOUS IUCD OR CONTRACEPTIVE USE?
HF7_Q1303__5
ANY HISTORY OF HIGH BLOOD PRESSURE?:ANY PAP SMEARS?
HF7_Q1303__6
ANY HISTORY OF HIGH BLOOD PRESSURE?:ANY HEART DISEASE, LIVER DISEASE, MALARIA, G
HF7_Q1303__7
ANY HISTORY OF HIGH BLOOD PRESSURE?:FAMILY HISTORY OF HEREDITARY D ISEASE?
HF7_Q1303__8
ANY HISTORY OF HIGH BLOOD PRESSURE?:ANY ALLERGIES TO MEDICATIONS?
HF7_Q1303__9
ANY HISTORY OF HIGH BLOOD PRESSURE?:PRESENT/CURRENT SMOKER?
HF7_Q1303__10
ANY HISTORY OF HIGH BLOOD PRESSURE?:ANY HISTORY OF ALCOHOL USE?
HF7_Q1303__11
ANY HISTORY OF HIGH BLOOD PRESSURE?:ANY HISTORY OF ILLICIT DRUG USE?
HF7_Q1303__12
ANY HISTORY OF HIGH BLOOD PRESSURE?:BLOOD TRANSFUSION
HF7_Q1303__13
ANY HISTORY OF HIGH BLOOD PRESSURE?:JAUNDICE
HF7_Q1304__1
BODY HEIGHT:BODY HEIGHT
HF7_Q1304__2
BODY HEIGHT:BODY WEIGHT
HF7_Q1304__3
BODY HEIGHT:BLOOD PRESSURE
HF7_Q1304__4
BODY HEIGHT:TEMPERATURE
HF7_Q1304__5
BODY HEIGHT:RESPIRATORY RATE
HF7_Q1304__6
BODY HEIGHT:PALPATE ABDOMEN
HF7_Q1304__7
BODY HEIGHT:LISTEN TO FETAL HEARTBEAT
HF7_Q1304__8
BODY HEIGHT:PELVIC EXAMINATION
HF7_Q1304__9
BODY HEIGHT:CHECK FOR OEDEMA/SWELLING OF THE FEET, ANKLE OR FACE
HF7_Q1304__10
BODY HEIGHT:MEASURE SIZE OF WOMB (FUNDAL HEIGHT OR UTERINE HEIGHT)
HF7_Q1304__11
BODY HEIGHT:ADMINISTER TETANUS TOXOID
HF7_Q1304__12
BODY HEIGHT:EYE FOR JAUNDICE/PALLOR
HF7_Q1304__13
BODY HEIGHT:NECK FOR GOITRE
HF7_Q1304__14
BODY HEIGHT:BREAST FOR SORE, INVERSION OR SWOLLEN
HF7_Q1304__15
BODY HEIGHT:VERICOSE VEIN IN THE LEGS
HF7_Q1305__1
PREGNANCY TEST:PREGNANCY TEST
HF7_Q1305__2
PREGNANCY TEST:HEMOGLOBIN TEST
HF7_Q1305__3
PREGNANCY TEST:URINE TEST FOR DIABETES
HF7_Q1305__4
PREGNANCY TEST:URINE PROTEIN
HF7_Q1305__5
PREGNANCY TEST:ULTRASOUND
HF7_Q1305__6
PREGNANCY TEST:BLOOD PLATELETS COUNT
HF7_Q1305__7
PREGNANCY TEST:LIVER ENZYMES
HF7_Q1305__8
PREGNANCY TEST:SERUM UREA AND CREATININE
HF7_Q1305__9
PREGNANCY TEST:HIV TEST
HF7_Q1305__10
PREGNANCY TEST:STI TEST - SYPHILLIS AND/OR GONORRHEA
HF7_Q1305__11
PREGNANCY TEST:RUBELLA ANTIBODIES
HF7_Q1305__12
PREGNANCY TEST:BLOOD GROUPING AND CROSS-MATCHIING
HF7_Q1306__1
13.06: What would you prescribe/provide to Mrs. Sibeso?:INSECTICIDE TREATED MOS
HF7_Q1306__2
13.06: What would you prescribe/provide to Mrs. Sibeso?:IRON / FOLIC ACID SUPPL
HF7_Q1306__3
13.06: What would you prescribe/provide to Mrs. Sibeso?:ADMINISTER TETANUS TOXO
HF7_Q1306__4
13.06: What would you prescribe/provide to Mrs. Sibeso?:INTERMITTENT PREVENTIVE
HF7_Q1307__1
13.07: What kind of advice would you give to Mrs. Sibeso?:NUTRITION
HF7_Q1307__2
13.07: What kind of advice would you give to Mrs. Sibeso?:IRON / FOLIC ACID SUP
HF7_Q1307__3
13.07: What kind of advice would you give to Mrs. Sibeso?:DANGER SIGNS FOR EMER
HF7_Q1307__4
13.07: What kind of advice would you give to Mrs. Sibeso?:BREASTFEEDING
HF7_Q1307__5
13.07: What kind of advice would you give to Mrs. Sibeso?:CONTRACEPTION
HF7_Q1307__6
13.07: What kind of advice would you give to Mrs. Sibeso?:HIV VOLUNTARY COUNSEL
HF7_Q1307__7
13.07: What kind of advice would you give to Mrs. Sibeso?:USE OF INSECTICIDE TR
HF7_Q1308__1
13.08: What follow-up action would you take for Mrs. Sibeso?:COMPLETE PRENATAL
HF7_Q1308__2
13.08: What follow-up action would you take for Mrs. Sibeso?:SCHEDULE ANOTHER P
HF7_Q1308__3
13.08: What follow-up action would you take for Mrs. Sibeso?:SCHEDULE INSTITUTI
HF7_Q1308__4
13.08: What follow-up action would you take for Mrs. Sibeso?:BIRTH PREPAREDNESS
HF7_Q1402
15.02. Are you aware that this facility participates in the Nigeria State Health
HF7_Q1401A__1
14.01A. Which of the following indicators are incentivized by the Complementary
HF7_Q1401A__2
14.01A. Which of the following indicators are incentivized by the Complementary
HF7_Q1401A__3
14.01A. Which of the following indicators are incentivized by the Complementary
HF7_Q1401A__4
14.01A. Which of the following indicators are incentivized by the Complementary
HF7_Q1401A__5
14.01A. Which of the following indicators are incentivized by the Complementary
HF7_Q1401A__6
14.01A. Which of the following indicators are incentivized by the Complementary
HF7_Q1401A__7
14.01A. Which of the following indicators are incentivized by the Complementary
HF7_Q1401A__8
14.01A. Which of the following indicators are incentivized by the Complementary
HF7_Q1401B__1
14.01B. Which of the following indicators are incentivized by the Minimum Packag
HF7_Q1401B__2
14.01B. Which of the following indicators are incentivized by the Minimum Packag
HF7_Q1401B__3
14.01B. Which of the following indicators are incentivized by the Minimum Packag
HF7_Q1401B__4
14.01B. Which of the following indicators are incentivized by the Minimum Packag
HF7_Q1401B__5
14.01B. Which of the following indicators are incentivized by the Minimum Packag
HF7_Q1401B__6
14.01B. Which of the following indicators are incentivized by the Minimum Packag
HF7_Q1401B__7
14.01B. Which of the following indicators are incentivized by the Minimum Packag
HF7_Q1401B__8
14.01B. Which of the following indicators are incentivized by the Minimum Packag
HF7_Q1403
15.03 Can you tell me how much top-up payment, if any, YOUR FACILITY received in
HF7_Q1404A__1
15.04. If you wanted to increase your facility’s payment from the PBF program fo
HF7_Q1404A__2
15.04. If you wanted to increase your facility’s payment from the PBF program fo
HF7_Q1404A__3
15.04. If you wanted to increase your facility’s payment from the PBF program fo
HF7_Q1404A__4
15.04. If you wanted to increase your facility’s payment from the PBF program fo
HF7_Q1404A__5
15.04. If you wanted to increase your facility’s payment from the PBF program fo
HF7_Q1404A__6
15.04. If you wanted to increase your facility’s payment from the PBF program fo
HF7_Q1404A__7
15.04. If you wanted to increase your facility’s payment from the PBF program fo
HF7_Q1404A__8
15.04. If you wanted to increase your facility’s payment from the PBF program fo
HF7_Q1404A__9
15.04. If you wanted to increase your facility’s payment from the PBF program fo
HF7_Q1404A__10
15.04. If you wanted to increase your facility’s payment from the PBF program fo
HF7_Q1404A__11
15.04. If you wanted to increase your facility’s payment from the PBF program fo
HF7_Q1404A__12
15.04. If you wanted to increase your facility’s payment from the PBF program fo
HF7_Q1404A__13
15.04. If you wanted to increase your facility’s payment from the PBF program fo
HF7_Q1404A__14
15.04. If you wanted to increase your facility’s payment from the PBF program fo
HF7_Q1404A__15
15.04. If you wanted to increase your facility’s payment from the PBF program fo
HF7_Q1404A__16
15.04. If you wanted to increase your facility’s payment from the PBF program fo
HF7_Q1404A__17
15.04. If you wanted to increase your facility’s payment from the PBF program fo
HF7_Q1404A__18
15.04. If you wanted to increase your facility’s payment from the PBF program fo
HF7_Q1404A__19
15.04. If you wanted to increase your facility’s payment from the PBF program fo
HF7_Q1404A__20
15.04. If you wanted to increase your facility’s payment from the PBF program fo
HF7_Q1404A__21
15.04. If you wanted to increase your facility’s payment from the PBF program fo
HF7_Q1404A__22
15.04. If you wanted to increase your facility’s payment from the PBF program fo
HF7_Q1404A__23
15.04. If you wanted to increase your facility’s payment from the PBF program fo
HF7_Q1404A__24
15.04. If you wanted to increase your facility’s payment from the PBF program fo
HF7_Q1404B__1
15.04. If you wanted to increase your facility’s payment from the PBF program fo
HF7_Q1404B__2
15.04. If you wanted to increase your facility’s payment from the PBF program fo
HF7_Q1404B__3
15.04. If you wanted to increase your facility’s payment from the PBF program fo
HF7_Q1404B__4
15.04. If you wanted to increase your facility’s payment from the PBF program fo
HF7_Q1404B__5
15.04. If you wanted to increase your facility’s payment from the PBF program fo
HF7_Q1404B__6
15.04. If you wanted to increase your facility’s payment from the PBF program fo
HF7_Q1404B__7
15.04. If you wanted to increase your facility’s payment from the PBF program fo
HF7_Q1404B__8
15.04. If you wanted to increase your facility’s payment from the PBF program fo
HF7_Q1404B__9
15.04. If you wanted to increase your facility’s payment from the PBF program fo
HF7_Q1404B__10
15.04. If you wanted to increase your facility’s payment from the PBF program fo
HF7_Q1404B__11
15.04. If you wanted to increase your facility’s payment from the PBF program fo
HF7_Q1404B__12
15.04. If you wanted to increase your facility’s payment from the PBF program fo
HF7_Q1404B__13
15.04. If you wanted to increase your facility’s payment from the PBF program fo
HF7_Q1404B__14
15.04. If you wanted to increase your facility’s payment from the PBF program fo
HF7_Q1404B__15
15.04. If you wanted to increase your facility’s payment from the PBF program fo
HF7_Q1404B__16
15.04. If you wanted to increase your facility’s payment from the PBF program fo
HF7_Q1404B__17
15.04. If you wanted to increase your facility’s payment from the PBF program fo
HF7_Q1404B__18
15.04. If you wanted to increase your facility’s payment from the PBF program fo
HF7_Q1404B__19
15.04. If you wanted to increase your facility’s payment from the PBF program fo
HF7_Q1404B__20
15.04. If you wanted to increase your facility’s payment from the PBF program fo
HF7_Q1404B__21
15.04. If you wanted to increase your facility’s payment from the PBF program fo
HF7_Q1404B__22
15.04. If you wanted to increase your facility’s payment from the PBF program fo
HF7_Q1405__1
15.05 Generally speaking, what else determine the level of payment for services:
HF7_Q1405__2
15.05 Generally speaking, what else determine the level of payment for services:
HF7_Q1405__3
15.05 Generally speaking, what else determine the level of payment for services:
HF7_Q1405__4
15.05 Generally speaking, what else determine the level of payment for services:
HF7_Q1405__5
15.05 Generally speaking, what else determine the level of payment for services:
HF7_Q1405__6
15.05 Generally speaking, what else determine the level of payment for services:
HF7_Q1405__7
15.05 Generally speaking, what else determine the level of payment for services:
HF7_Q1405_os
14.05_Oth. Specify the other factor that determines the level of payment for ser
HF7_Q1406
15.06. In naira, can you tell me what the PBF fee for a NORMAL DELIVERY is?
HF7_Q1407
15.07. In naira, can you tell me what the PBF fee for a POSTNATAL CONSULTATION
HF7_Q1408
15.08. In naira, can you tell me what the PBF fee for a NEW CLIENT PUT UNDER ARV
HF7_Q1409
15.09. Are you aware that under the PBF program target levels are set for certai
HF7_Q1410
15.10 . Can you tell me what the percentage target is for 2017 for NORMAL DELIVE
HF7_Q1411
15.11 . Can you tell me what the percentage target is for 2017 for POSTNATAL CON
HF7_Q1412
15.12. Can you tell me what the percentage target is for 2017 for NEW PATIENTS
HF7_Q1413
15.13. Can you tell me the percentage quality bonus that health facilities can r
partograph_check
INTERVIEWER: PLEASE ASK THE RESPONDENT IF THEY KNOW HOW TO READ A PARTOGRAPH. YO
arm
INTERVIEWER: SELECT THE EXPERIMENT ARM FOR THE INTERVIEWER
correct
INTERVIEWER: SELECT WHETHER THE RESPONDENT WILL BE ASSIGNED TO OPTION 1 OR OPTIO
HF7_Q1501
15.01. Based on Mrs. Florence's partograph, your colleague suggests that you %Q1
HF7_Q1502__1
15.02. Assume Mrs. Adeola is your patient. What clinically indicated actions wou
HF7_Q1502__2
15.02. Assume Mrs. Adeola is your patient. What clinically indicated actions wou
HF7_Q1502__3
15.02. Assume Mrs. Adeola is your patient. What clinically indicated actions wou
HF7_Q1502__4
15.02. Assume Mrs. Adeola is your patient. What clinically indicated actions wou
HF7_Q1502__5
15.02. Assume Mrs. Adeola is your patient. What clinically indicated actions wou
HF7_Q1502__6
15.02. Assume Mrs. Adeola is your patient. What clinically indicated actions wou
HF7_Q1502__7
15.02. Assume Mrs. Adeola is your patient. What clinically indicated actions wou
HF7_Q1502__8
15.02. Assume Mrs. Adeola is your patient. What clinically indicated actions wou
HF7_Q1502__9
15.02. Assume Mrs. Adeola is your patient. What clinically indicated actions wou
HF7_Q1502__10
15.02. Assume Mrs. Adeola is your patient. What clinically indicated actions wou
HF7_Q1502__11
15.02. Assume Mrs. Adeola is your patient. What clinically indicated actions wou
HF7_Q1502__12
15.02. Assume Mrs. Adeola is your patient. What clinically indicated actions wou
HF7_Q1502__13
15.02. Assume Mrs. Adeola is your patient. What clinically indicated actions wou
HF7_Q1502__14
15.02. Assume Mrs. Adeola is your patient. What clinically indicated actions wou
HF7_Q1502__15
15.02. Assume Mrs. Adeola is your patient. What clinically indicated actions wou
HF7_Q1502__16
15.02. Assume Mrs. Adeola is your patient. What clinically indicated actions wou
HF7_Q1502_os
15.02_Oth. Please specify other action
HF7_Q1503__1
15.03. Assume Mrs. Blessing is your patient. What clinically indicated actions w
HF7_Q1503__2
15.03. Assume Mrs. Blessing is your patient. What clinically indicated actions w
HF7_Q1503__3
15.03. Assume Mrs. Blessing is your patient. What clinically indicated actions w
HF7_Q1503__4
15.03. Assume Mrs. Blessing is your patient. What clinically indicated actions w
Total: 633
Back to Catalog